Recent research have focused on the convergence of glucagon-like peptide-1|GIP|glucagon receptor activator therapies and DA communication. While GCGR stimulators are commonly employed for managing type 2 T2DM, their emerging effects on reinforcement circuits, specifically governed by dopamine networks, are gaining significant focus. This article… Read More